Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
KIMS already have a multi-specialty hospital and gastro unit at Vizag
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Subscribe To Our Newsletter & Stay Updated
